Is sotatercept, which traps activins and growth differentiation factors, a new dawn in treating pulmonary arterial hypertension (PAH)?

.

Source: Expert Opinion on Biological Therapy - June 8, 2023 Category: Drugs & Pharmacology Authors: Sheila A Doggrell Source Type: research